The hen's egg test for micronucleus induction (HET-MN): validation data set.


Journal

Mutagenesis
ISSN: 1464-3804
Titre abrégé: Mutagenesis
Pays: England
ID NLM: 8707812

Informations de publication

Date de publication:
04 05 2022
Historique:
received: 01 02 2021
accepted: 27 05 2021
pubmed: 4 6 2021
medline: 10 5 2022
entrez: 3 6 2021
Statut: ppublish

Résumé

The classical in vitro genotoxicity test battery is known to be sensitive for indicating genotoxicity. However, a high rate of 'misleading positives' was reported when three assays were combined as required by several legislations. Despite the recent optimisations of the standard in vitro tests, two gaps could hardly be addressed with assays based on 2D monolayer cell cultures: the route of exposure and a relevant intrinsic metabolic capacity to transform pro-mutagens into reactive metabolites. Following these considerations, fertilised chicken eggs have been introduced into genotoxicity testing and were combined with a classical read-out parameter, the micronucleus frequency in circulating erythrocytes, to develop the hen's egg test for micronucleus induction (HET-MN). As a major advantage, the test mirrors the systemic availability of compounds after oral exposure by reflecting certain steps of Absorption, Distribution, Metabolism, Excretion (ADME) without being considered as an animal experiment. The assay is supposed to add to a toolbox of assays to follow up on positive findings from initial testing with classical in vitro assays. We here report on a validation exercise, in which >30 chemicals were tested double-blinded in three laboratories. The specificity and sensitivity of the HET-MN were calculated to be 98 and 84%, respectively, corresponding to an overall accuracy of 91%. A detailed protocol, which includes a picture atlas detailing the cell and micronuclei analysis, is published in parallel (Maul et al. Validation of the hen's egg test for micronucleus induction (HET-MN): detailed protocol including scoring atlas, historical control data and statistical analysis).

Identifiants

pubmed: 34080017
pii: 6291394
doi: 10.1093/mutage/geab016
pmc: PMC9071061
doi:

Substances chimiques

Mutagens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

61-75

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society.

Références

Crit Rev Toxicol. 2005 Dec;35(10):783-835
pubmed: 16468500
J Morphol. 1951 Jan;88(1):49-92
pubmed: 24539719
ALTEX. 1997;14(3):111-113
pubmed: 11178496
Genes Environ. 2016 Oct 1;38:18
pubmed: 27733885
Biosci Rep. 1984 Sep;4(9):729-35
pubmed: 6509158
Mutagenesis. 2021 Apr 28;36(1):19-35
pubmed: 32152633
Mutat Res. 2005 Jul 4;584(1-2):1-256
pubmed: 15979392
Mutat Res. 1999 Mar 8;424(1-2):237-47
pubmed: 10064864
Carcinogenesis. 1991 Jun;12(6):1057-9
pubmed: 2044184
Mutat Res Genet Toxicol Environ Mutagen. 2018 Mar;827:27-41
pubmed: 29502735
Mutat Res. 2009 Aug;678(1):30-7
pubmed: 19559100
Mutat Res. 2000 Nov 20;455(1-2):81-95
pubmed: 11113469
Adv Morphog. 1964;4:197-245
pubmed: 14284231
Mutat Res. 2008 Feb 29;650(2):150-64
pubmed: 18201925
Mutat Res. 1983 Dec;123(3):363-410
pubmed: 6358881
Mutagenesis. 2008 Jul;23(4):271-83
pubmed: 18326866
Mutat Res. 1977 Mar;42(3):335-42
pubmed: 323699
Mutat Res. 2006 Sep 5;607(2):192-204
pubmed: 16781186
J Vet Med Sci. 2017 Jul 28;79(7):1310-1317
pubmed: 28603212
J Pharm Sci. 1991 Aug;80(8):761-4
pubmed: 1791537
Mutat Res Genet Toxicol Environ Mutagen. 2020 Feb - Mar;850-851:503135
pubmed: 32247552
Int J Pharm. 2017 May 15;523(1):15-32
pubmed: 28323096
Altern Lab Anim. 2004 Nov;32(5):467-72
pubmed: 15656771
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2014 Feb;70(Pt 1):54-62
pubmed: 24441128
Mutat Res. 2010 Oct 29;702(2):135-8
pubmed: 20176128
Lymphology. 1983 Jun;16(2):83-9
pubmed: 6350736
Mutat Res. 2012 Aug 30;747(1):118-134
pubmed: 22580102
Mutat Res. 2013 Sep 18;757(1):68-78
pubmed: 23892231
Regul Toxicol Pharmacol. 2010 Jul-Aug;57(2-3):315-24
pubmed: 20382194
Mutagenesis. 2021 Apr 28;36(1):1-17
pubmed: 33544138
Mutat Res. 1981 Oct;83(3):419-30
pubmed: 7035923
Mutat Res. 1997 Nov 27;394(1-3):163-75
pubmed: 9434855
Mutat Res. 2002 Feb 15;514(1-2):59-76
pubmed: 11815245
Mutagenesis. 2022 May 4;37(2):76-88
pubmed: 34313790
Teratog Carcinog Mutagen. 1989;9(2):111-8
pubmed: 2568020
Mutat Res. 2002 Nov 26;521(1-2):201-8
pubmed: 12438016
Food Chem Toxicol. 2003 Apr;41(4):561-73
pubmed: 12615129
Mutat Res Genet Toxicol Environ Mutagen. 2016 Jan 1;795:7-30
pubmed: 26774663
Arch Toxicol. 2008 Aug;82(8):493-512
pubmed: 18496671
Carcinogenesis. 1990 Sep;11(9):1551-6
pubmed: 2401044
Int J Med Chem. 2017;2017:7386125
pubmed: 29362676
Mutat Res. 1991 Jun;263(2):115-7
pubmed: 2046703
Mutat Res Genet Toxicol Environ Mutagen. 2018 Jan;825:51-58
pubmed: 29307375

Auteurs

Kerstin Reisinger (K)

Henkel AG & Co KGaA, Duesseldorf, Germany.

Dagmar Fieblinger (D)

Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Andreas Heppenheimer (A)

ICCR-Roßdorf GmbH (formerly Harlan CCR GmbH), Rossdorf, Germany.

Jürgen Kreutz (J)

Henkel AG & Co KGaA, Duesseldorf, Germany.

Manfred Liebsch (M)

Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Andreas Luch (A)

Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Katrin Maul (K)

Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Albrecht Poth (A)

ICCR-Roßdorf GmbH (formerly Harlan CCR GmbH), Rossdorf, Germany.

Pamela Strauch (P)

ICCR-Roßdorf GmbH (formerly Harlan CCR GmbH), Rossdorf, Germany.

Eva Dony (E)

ICCR-Roßdorf GmbH (formerly Harlan CCR GmbH), Rossdorf, Germany.

Markus Schulz (M)

ICCR-Roßdorf GmbH (formerly Harlan CCR GmbH), Rossdorf, Germany.

Thorsten Wolf (T)

University of Osnabrueck, Osnabrueck, Germany.

Ralph Pirow (R)

Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH